July 26, 2021 • Press Release [3]

Study Shows Increase in Risk of Renal Failure Following Lytic Therapy for Acute Deep Vein Thrombosis [4]

A large single-center retrospective study reveals the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower extremity deep vein thrombosis (DVT) is a high as 22%.

July 1, 2021 • Press Release [3]

The Society for Vascular Surgery Releases Clinical Practice Guidelines and Implementation Document on the Management of Extracranial Cerebrovascular Disease [5]

The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial carotid artery disease.  Since stroke prevention related to carotid artery disease is of major interest to vascular surgeons, the documents aim to use the existing clinical evidence to ensure patients with atherosclerotic occlusive disease in the carotid arteries receive appropriate treatment and care.

June 28, 2021 • Press Release [3]

The Society for Vascular Surgery Releases Clinical Practice Guidelines on Popliteal Artery Aneurysms [6]

The Society for Vascular Surgery (SVS) has released a new clinical practice guideline to ensure that patients with aneurysms of the popliteal arteries (located behind the knee) receive appropriate treatment and care. Aneurysms of the popliteal artery are the most common aneurysms outside of the brain and abdominal aorta.

June 24, 2021 • Press Release [3]

Exact Symptom Status Better Predicts Outcomes after Transfemoral Carotid Artery Stenting [7]

Further stratification according to preprocedural symptoms in patients undergoing transfemoral carotid artery stenting (TFCAS) improves the preoperative risk assessment, a review of the Society of Vascular Surgery’s Vascular Quality Initiative (VQI) data suggests.

June 22, 2021 • Press Release [3]

The Society for Vascular Surgery Elects Joseph L. Mills, MD, of Baylor College of Medicine to 2021-2022 Officer Lineup [8]

The Society for Vascular Surgery (SVS), the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease, today announced its officers for 2021-2022. Several officers shifted roles and Dr. Joseph L. Mills was elected vice president at the SVS annual business meeting held virtually on June 16, 2021.